- The rising burden of diabetes worldwide, particularly in Europe region, pen needles have become an essential part of diabetes management. Innovations in needle design, including ultra-fine tips and safety-engineered variants, have made self-administration safer and more effective
- Pen needles are essential components for delivering injectable medications, particularly insulin, in a convenient and minimally invasive manner. The market is experiencing significant growth due to rising diabetes incidence, technological advancements in needle design, and increased patient awareness.
- The demand for pen needles is significantly driven by the growing diabetic population, favorable reimbursement policies, and the convenience offered by pen devices over traditional syringes
- Germany, dominates the Europe Pen Needles market due to the prevalence of advanced healthcare infrastructure and rising prevalence of the target disease
- France is projected to register the highest CAGR due to rising expenditure to develop healthcare infrastructure, ever-rising diabetic population, and rising awareness about the availability treatment options
- Insulin therapy is expected to dominate the market in 2025 with the largest market share of 43.3%, due to the widespread incidence of type 1 and type 2 diabetes and reliance on insulin injections for glycemic control
